Earnings NewsHealthcareEntera Bio GAAP EPS of -$0.47 beats by $0.58, revenue of $0.57M beats by $0.03MMar. 08, 2022 6:44 AM ETEntera Bio Ltd. (ENTX)By: Deepa Sarvaiya, SA News Editor Entera Bio press release (NASDAQ:ENTX): FY GAAP EPS of -$0.47 beats by $0.58. Revenue of $0.57M (+54.1% Y/Y) beats by $0.03M. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsBiotechs post record gains in November amid improving outlookAmazon is a multi-trillion dollar giant. Oppenheimer thinks it can get even bigger.Earnings week ahead: DocuSign, NIO, Broadcom, GameStop and moreCharles Schwab files for mixed shelfActivist investor Petrus Advisers discloses more than 5% stake in adtech firm CriteoSee More »About ENTXSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgENTX--Entera Bio Ltd.EQ--Equillium, Inc.PIRS--Pieris Pharmaceuticals, Inc.NCNA--NuCana plcAPTO--Aptose Biosciences Inc.CompareTrending AnalysisTrending News